Arzeda designs enzymes for products ranging from laundry detergent to stevia. But when it comes time to manufacture at commercial scale, the Seattle-based startup often has to look overseas.
That’s why, when a federal biotechnology commission visited Seattle on Tuesday, the industry came forward with a problem: They have the science, but lack the infrastructure and workforce pipeline to keep innovation on U.S. soil.
Arzeda’s designs reach an estimated 1.8 billion consumers worldwide, and the company has spent the better part of two decades building its technology. The company’s enzymes, sometimes designed in days rather than weeks thanks to…
Read the full article at GEEKWIRE.COM


